@article {7051,
	title = {The author and colleagues reply: Bueno},
	journal = {New England Journal of Medicine},
	volume = {375},
	year = {2016},
	note = {Export Date: 18 February 2017References: Murphy, M.F., Dumont, L.J., Greinacher, A., Interference of new drugs with compatibility testing for blood transfusion (2016) N Engl J Med, 375, pp. 295-296;(2016) Summary of Product Characteristics: DARZALEX 20 mg/mL Concentrate for Solution for Infusion, , http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004077/WC500207296.pdf, London: European Medicines Agency; 
Regan, D.M., Markowitz, M.A., Mitigating the anti-CD38 interference with serologic testing (2016) AABB Bulletin $\#$16-02, , Bethesda, MD:American Association of Blood Banks; 
Palumbo, A., Chanan-Khan, A., Weisel, K., Daratumumab, bortezomib, and dexamethasone for multiple myeloma (2016) N Engl J Med, 375, pp. 754-766
},
	month = {2016},
	pages = {2497 - 2498},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007099165\&doi=10.1056\%2fNEJMc1613868\&partnerID=40\&md5=cdb6cedb6f2d5ee648f6b23f6ba3ad77},
	author = {Dimopoulos, M.A. and Sonneveld, P. and Sun, H.}
}
